Were women filing pelvic mesh lawsuits in New Jersey overcharged a 40% contingency fee by their Texas lawyers? Should they be able to recoup millions as a result?

For many years, Congress (especially women in Congress) criticized the FDA for not requiring companies applying for approval to include enough women, people of color, and people over 65 in clinical trials. As a result, many drugs and devices were approved on the basis of studies primarily of relatively young, mostly white males.

A former FDA IT project manager left the agency to focus on patient safety and on finding the numbers needed for true patient safety and advocacy.

Bayer stopped selling its Essure birth control device in the U.S. late in 2018 due to thousands of reports from the public of complications.